NeuroSigma
PrivateLast Round
Corporate Funding
Dec 15, 2025
Total Funding Raised
$9.6M
Momentum Score
50 /100
Company Overview
NeuroSigma is a bioelectronic medical device company that develops and commercializes non-invasive trigeminal nerve stimulation (TNS) technologies for treating disorders such as pediatric ADHD, epilepsy, and depression.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Health IoT
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroSigma Comps
Public and private peers based on sector, stage, and business model.
NeuroSigma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 15, 2025 | ||||
| Debt Conversion | Dec 8, 2021 | ||||
| Corporate Funding | Dec 8, 2021 | ||||
| Debt | Sep 21, 2020 | ||||
| Grant | Feb 4, 2013 |
NeuroSigma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| KT Corporation | Corporate Funding |
| Checkmate Capital | Corporate Funding, Debt |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors grew 115% MoM, reaching 4K.
- Dec 15, 2025
$1M raised in corporate funding.
NeuroSigma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroSigma's valuation, stock price, and market status.
